Pseudomonas organisms other than Pseudomonas aeruginosa as emerging bacterial pathogens in patients with human immunodeficiency virus infection

Infectious Diseases in Clinical Practice

Volumn 9, Issue 2, 2000, Pages 79-87

  Manfredi, Roberto ^a   Nanetti, Anna ^a   Ferri, Morena ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PSEUDOMONAS AERUGINOSA;

EID: 0033969255     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-200009020-00010     Document Type: Article

References (53)

1. Kovacs A, Leaf HL, Simberkoff MS. Management of the HIV-infected patient: bacterial infections. Med Clin North Am 1997;81:319-43.
2. Brettle RP. Bacterial infections in HIV: the extent and nature of the problem. Int J STD AIDS 1997;8:5-15.
3. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995;333:845-51.
4. Furman AC, Jacobs J, Sepkowitz KA. Lung abscess in patients with AIDS. Clin Infect Dis 1996;22:81-5.
5. Bernard E, Carles M, Pradier C, Ozouf N, Dellamonica P. Septicémies communautaires et nosocomiales chez le patient infecté par le virus de l'immunodéficience humaine. Presse Med 1996;25:746-50.
6. Frank U, Daschner FD, Schulgen G, et al. Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin Infect Dis 1997;25:318-20.
7. DeMarais PL, Gertzen J, Weinstein RA. Nosocomial infections in human immunodeficiency virus-infected patients in a long-term care setting. Clin Infect Dis 1997;25: 1230-2.
8. Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:51-7.
9. Tumbarello M, Tacconelli E, Caponera S, et al. The impact of bacteraemia on HIV infection: nine years experience in a large Italian university hospital. J Infect 1995;31:123-31.
10. Goetz AM, Squier C, Wagener MM, et al. Nosocomial infections in the human immunodeficiency virus-infected patient: a two-year survey. Am J Infect Control 1994;23: 334-9.
11. Flores G, Stavola JJ, Noel GJ. Bacteremia due to Pseudomonas aeruginosa in children with AIDS. Clin Infect Dis 1993;16:706-8.
12. Dropulic LK, Leslie JM, Eldred LJ, et al. Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J Infect Dis 1995;171:930-7.
13. Fichtenbaum CJ, Woeltje KF, Powderly WG. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 1994;19:417-22.
14. Shepp DH, Tang ITL, Ramundo MB, et al. Serious Pseudomonas aeruginosa infection in AIDS. J Acquir Immune Defic Syndr 1994;7:823-31.
15. Moore DA, Gazzard BG, Nelson MR. Central venous line infections in AIDS. J Infect 1997:34:35-40.
16. Manfredi R, Nanetti A, Ferri M, et al. Profile and trend of antimicrobial resistance of non-opportunistic bacterial pathogens isolated from patients with HIV infection. J Antimicrob Chemother 1996;38:910-3.
17. Manfredi R, Nanetti A, Ferri M, et al. Xanthomonas maltophilia: an emerging pathogen in patients with HIV disease. Int J STD AIDS 1998;9:201-7.
18. Manfredi R, Nanetti A, Ferri M, et al. Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1997;16:933-8.
19. Hern JD, Ghufoor K, Jayaraj SM, et al. ENT manifestations of Pseudomonas aeruginosa infection in HIV and AIDS. Int J Clin Pract 1998;52:141-4.
20. Asboe D, Gant V, Aucken HM, et al. Persistence of Pseudomonas aeruginosa strains in respiratory infection in AIDS patients. AIDS 1998;12:1771-5.
21. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis 1994;26: 635-42.
22. Roilides E, Butler KM, Husson RN, et al. Pseudomonas infections in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992;11:547-53.
23. Edge MD, Rimland D. Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. AIDS 1996;10:1635-9.
24. Schuster MG, Norris AH. Community-acquired Pseudomonas aeruginosa pneumonia in patients with HIV infection. AIDS 1994;8:1437-41.
25. Verghese A, Al Samman M, Nabhan D, et al. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection. Arch Intern Med 1994;154:2086-91.
26. Nelson MR, Shanson DC, Barter GJ, et al. Pseudomonas septicaemia associated with HIV. AIDS 1991;5:761-3.
27. Skoutelis AT, Murphy RL, MacDonell KB, et al. Indwelling central venous catheter infections in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 1990;3:335-42.
28. Franzetti F, Cernuschi M, Esposito R, et al. Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med 1992;231:437-43.
29. Baron AD, Hollander H. Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dis 1993;148:992-6.
30. Kielhofner M, Atmar RL, Hammill RJ, et al. Life-threatening Pseudomonas aeruginosa infection in patients with human immunodeficiency virus infection. Clin Infect Dis 1992;14:403-11.
31. Tumbarello M, Tacconelli E, De Gaetano K, et al. Bacterial pneumonia in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:39-45.
32. Roilides E, Marshall D, Venzon D, et al. Bacterial infections in human immunodeficiency virus type 1-infected children: the impact of central venous catheters and antiretroviral agents. Pediatr Infect Dis J 1991;10:313-9.
33. Roig P, Orti A, Navarro V. Meningitis due to Pseudomonas stutzeri in a patient infected with human immunodeficiency virus. Clin Infect Dis 1996;22:587-8.
34. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990;69:296-306.
35. Ensor E, Humphreys H, Peckham D, et al. Is Eurkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy? J Hosp Infect 1996;32:9-15.
36. Govan JR, Hughes JE, Vandamme P. Burkholaeria cepacia: medical, taxonomic, and ecological issues. J Med Microbiol 1996;45:395-407.
37. Cazzola G, Amalfitano G, Tonolli E, et al. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Acta Paediatr 1996;85:554-7.
38. Pitt TL, Kaufmann ME, Patel PS, et al. Type characterization and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 1996;44:203-10.
39. Martino R, Martinez C, Pericas R, et al. Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematologic neoplasias and solid tumors. Eur J Clin Microbiol Infect Dis 1996;15:610-5.
40. Burgos F, Torres A, Gonzalez J, et al. Bacterial colonization as a potential source of nosocomial respiratory infections in two type of spirometer. Eur Respir J 1996;9: 2612-7.
41. Maningo E, Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect 1995;31:89-92.
42. Spencer RC. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995;30 Suppl:453-64.
43. Hamill RJ, Houston ED, Georghiu PR, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med 1995;122: 762-6.
44. Speert DP, Bond M, Woodman RC, et al. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J Infect Dis 1994;170:1524-31.
45. Noble RC, Overman SB. Pseudomonas stutzen infection. A review of hospital isolates and a review of the literature. Diagn Microbiol Infect Dis 1994;19:51-6.
46. Keizur JJ, Lavin B, Leidich RB. Iatrogenic urinary tract infection with Pseudomonas cepacia after transrectal ultrasound guided needle biopsy of the prostate. J Urol 1993;149:523-6.
47. Muhdi K, Edenborough FP, Gumery L, et al. Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax 1996;51:374-7.
48. Kropec A, Lemmen S, Wursthorn M, et al. Combination effect of meropenem with aminoglycosides and teicoplanin on pseudomonas and enterococci. Infection 1994;22:306-8.
49. Tumbarello M, Tacconelli E, Cauda R, et al. Role of trimethoprim-sulphamethoxazole in preventing HIV-associated bacteraemia. AIDS 1997;11:1070-1.
50. Keiser P, Higgs E, Smith J. Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am J Med Sci 1996;312:118-22.
51. Domingo P, Ferre A, Baraldes MA, et al. Remission of relapsing Pseudomonas aeruginosa bronchopulmonary infection following antiretroviral therapy. Arch Intern Med 1998;158:929-30.
52. Nichols L, Balogh K, Silverman M. Bacterial infections in the acquired immune deficiency syndrome. Clinicopathologic correlations in a series of autopsy cases. Am J Clin Pathol 1989;92:787-90.
53. Caperna J, Barber RE, Toerner JG, et al. Estimation of the effect of neutropenia on rates of clinical bacteraemia in HIV-infected patients. Epidemiol Infect 1998;120:71-80.